Will GE fall behind rivals in bid to dominate healthcare industry?
This article was originally published in Clinica
After Siemens succeeded in pulling off two IVD acquisitions in the form of Bayer Diagnostics and DPC last year, little surprise that imaging rival GE came up with a deal to match in January when it said it was acquiring Abbott's lab diagnostics and point-of-care businesses for $8.1bn.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.